Skip to content

Lineage Cell Therapeutics, Inc.

LCTX· NYSECore metricsCIK 876343

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -11.97%
Market cap
$250.50M
252.95M shares
Filings
1,018
$1.43M
Q3 2026+53.2% FY25 yoy
$4.23M
Q3 2026N/M FY25 yoy
-$7.31M
Q3 2026N/M FY25 yoy
-$21.18M
Q3 2026derivedN/M FY25 yoy
-$0.03
Q3 2026N/M FY25 yoy
$26.50M
Q3 2026−10.9% FY25 yoy
$250.50M
142.9×
23.1×
3.7×
-10.56%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.990345.59%$0.8297past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$14.56MFY 2025
$14.70M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$14,556,000reported
FY 20242024-12-31$9,499,000reported
FY 20232023-12-31$8,945,000reported
FY 20222022-12-31$14,703,000reported
FY 20212021-12-31$4,341,000reported
FY 20202020-12-31$1,826,000reported
FY 20192019-12-31$3,515,000reported
FY 20182018-12-31$4,988,000reported
FY 20172017-12-31$3,458,000reported
FY 20162016-12-31$5,923,000reported
FY 20152015-12-31$7,036,000reported
FY 20142014-12-31$5,244,000 revisedreported

Segments

Revenue by Geography, FY2019 to FY2025FY2019Foreign · FY2019 · $1.42MUNITED STATES · FY2019 · $2.09MFY2020Foreign · FY2020 · $666.00KUNITED STATES · FY2020 · $1.16MFY2021Foreign · FY2021 · $446.00KUNITED STATES · FY2021 · $3.90MFY2022UNITED STATES · FY2022 · $14.70MFY2024FY2025Non-US · FY2025 · $2.50M
LineFY2025ShareChange
Non-US$2.50M17%—
Foreign———
UNITED STATES———
Total$14.56M

From the 10-K filed Mar 5, 2026LCTX

Biological products, except diagnostic substances

Lineage Cell Therapeutics, Inc. is the 58th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Lineage Cell Therapeutics, Inc. · CIK 876343 · Engraved from SEC EDGAR